Dr. Peter Bach Explains How Increasing Drug Prices Stifles Innovation

The American Journal of Managed Care
September 14, 2015

The ability to charge increasingly higher prices for drugs that already have competition on the market is stifling innovation and wasting resources and human subjects, according to Peter Bach, MD, MAPP, director of Memorial Sloan Kettering Cancer Center’s Center for Health Policy and Outcomes. Read the full article here.